home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> mail archive   |   Search register for news alert (free)  
  Arthur Bergen: ANNO: new meetings and positions; Nov 1995  
   

archive of HUM-MOLGEN mails

 
 

[Author Prev][Author Next][Thread Prev][Thread Next][Author Index][Topic Index]

To: Multiple recipients of list HUM-MOLGEN <HUM-MOLGEN@NIC.SURFNET.NL>
Subject: ANNO: new meetings and positions; Nov 1995
From: Arthur Bergen <bergen@AMC.UVA.NL>
Date: Fri, 1 Dec 1995 11:09:56 +0100

Note from the editor:

>From now on the ANNOs and CALLs updates will appear approximately once
a month, for your and our convenience.
In this ANNO: We have three new meetings, and a lot of new job
opportunities both in the academic and commercial field. If you are not
interested in a job yourself, please give a print-out to one of your
colleagues who might. Please acknowledge HUM-MOLGEN in your application!

Good luck and Have a nice day,

Arthur Bergen
***********************************************************************
New meetings (3)

This message was  originally submitted by BSmail7373@AOL.COM  to the HUM-MOLGEN


The Seventh Annual International Conference on Jewish Medical Ethics will
take place February 16-19, 1996 at the Radisson Hotel near San Francisco.
 Among the many topics to be considered will be genetic screening.  There
will be two plenary lectures on the topic, plus a panel discussion.  In
addition, there will be a seperate workshop held on the topic of Jewish
genetic diseases.

The conference is sponsored by the San Francisco-based Institute for Jewish
Medical Ethics.  Stanford University School of Medicine and the Institute for
Behavioral Health Care offer CME and CE credit for the course (up to 24.75
hours).

Anyone interested in the conference should include their street address in an
e-mail message to:  bsmal7373@aol.com.  Thank you.

Sincerely,

Barry L. Smail, Executive Director
Institute for Jewish Medical Ethics
1/800-258-4427
1/415-752-7333
FAX 752-5851
645 14th Ave., San Francisco, CA  94118

___________________________________________________________________________
Subj:   ANNO,NEWS: New Developements in Cancer Conference


This  message  was  originally  submitted by  alecs@MAIL.MED.UPENN.EDU  to  the
HUM-MOLGEN list at  NIC.SURFNET.NL.

NEW DEVELOPMENTS IN CANCER: Focus on Genetics in Clinical Practice
A conference sponsored by:
University of Pennsylvania Cancer Center

Friday, December 15, 1995
The Rittenhouse
210 West Rittenhouse Square
Philadelphia, Pennsylvania

To register, call (215-349-8387) or e-mail (jas@mail.med.upenn.edu),
including the following information: Name, Degree, SS#, Campus Address, Tel
#, Specialty, and Institutional Affiliation. For those registrants who are
not faculty, staff, fellows or students of the University of Pennsylvania
nor members of the University of Pennsylvania Cancer Network, please mail
your registration fee separately; $125-Physicians, $60-Nurses and other
health care professionals. Checks should be made payable to Trustees,
University of Pennsylvania. Send to: University of Pennsylvania Cancer
Center, 6 Penn Tower, 3400 Spruce St., Philadelphia, PA 19104. Checks must
be received by December 1, 1995.


Program Overview
The recent identification of genes that confer susceptibility to a number
of adult onset cancers has made the dream of predictive testing for cancer
risk a reality. These discoveries also hold the promise of greater
understanding of the basic mechanisms by which cancers arise.  However,
these strides present novel challenges to clinicians integrating the
discoveries into practice and educating patients about the power and
problems inherent in doing so.
This program will provide an overview of genetics in relation to clinical
practice, as well as updates on the genetics of breast, ovarian, colon and
thyroid cancers and melanoma.  Additional presentations will provide a
framework for utilizing this information in practice, discuss insurance
industry views of reimbursement for predictive testing and its relationship
to insurability, and give an overview of the ethical issues surrounding
predictive testing.
This program will be of interest to any health care provider likely to
encounter patients with a family history of cancer, including but not
limited to medical and surgical oncologists, family practitioners, general
surgeons, internists and obstetricians-gynecologists.  Nurses, genetic
counselors and other providers with similar patient populations are
encouraged to attend.

Program Objectives
At the completion of this conference, participants should be able to:
1.      Understand the basic principles of cancer genetics as they relate
to clinical practice.
2.      Review recent progress in the genetics of specific tumor types.
3.      Identify patients who are suitable candidates for susceptibility
testing for specific cancers and discuss the counseling needs of these
patients.
4.      Examine the ethical, legal and social implications of genetic
testing for cancer risk.


Conference Faculty

Chair
Barbara L. Weber, MD
Director, Breast Cancer Program
Associate Professor, Medicine (Hem/Onc) and Genetics
University of Pennsylvania Cancer Center

Faculty
C. Richard Boland, MD
Professor of Medicine
University of Michigan School of Medicine

Kathleen A. Calzone, RN, BSN
Nursing Coordinator,
Cancer Risk Evaluation Program
University of Pennsylvania Cancer Center

Arthur L. Caplan, PhD
Trustee, Professor of Bioethics
Director, Center for Bioethics University of Pennsylvania Medical Center

DuPont Guerry, IV, MD
Professor, Medicine (Hem/Onc)
University of Pennsylvania Cancer Center

Jeffrey A. Norton, MD
Professor, Surgery
Chief, Endocrine and Oncologic Surgery
Washington University School of Medicine

Kenneth Offit, MD, MPH
Chief, Clinical Genetics Service
Memorial Sloan-Kettering Cancer Center

Jill E. Stopfer, MS, CGC
Familial Cancer Coordinator, Cancer Risk Evaluation Program
University of Pennsylvania Cancer Center

Gary M. Owens, MD
Senior Medical Director
Independence Blue Cross


Accreditation
The University of Pennsylvania School of Medicine is accredited by the
Accreditation Council for Continuing Medical Education to sponsor
continuing medical education for physicians. The University of Pennsylvania
School of Medicine designates this continuing medical education activity
for 7 credit hours of Category 1 of the Physician's Recognition Award of
the American Medical Association.
This offering for 6.4 contact hours is provided by the University of
Pennsylvania School of Nursing, which is accredited as a provider of
continuing education in nursing by the American Nurses Credentialing
Centers Commission on Accreditation.

Registration and Fees
Because space is limited, early registration is advised. The registration
deadline is December 1, 1995.  Full refunds will be provided for
cancellations received by December 1, 1995. The registration fee is $125
for physicians and $60 for nurses and other health care professionals.
Registration includes tuition, luncheon and program materials.
Fees will be waived for faculty, staff, fellows and students of the
University of Pennsylvania and physicians and staff at hospitals in the
University of Pennsylvania Cancer Network.

-To register, call (215-349-8387) or e-mail (jas@mail.med.upenn.edu),
including the following information: Name, Degree, SS#, Campus Address, Tel
#, Specialty, and Institutional Affiliation. For those registrants who are
not faculty, staff, fellows or students of the University of Pennsylvania
nor members of the University of Pennsylvania Cancer Network, please mail
your registration fee separately; $125-Physicians, $60-Nurses and other
health care professionals. Checks should be made payable to Trustees,
University of Pennsylvania. Send to: University of Pennsylvania Cancer
Center, 6 Penn Tower, 3400 Spruce St., Philadelphia, PA 19104. Checks must
be received by December 1, 1995.-

Course Location
This program will be held at The Rittenhouse, which is located on the west
side of Rittenhouse Square in Center City, Philadelphia. The Rittenhouse is
5 minutes from Amtrak's train station at 30th and Market streets and 20
minutes from the Philadelphia Airport. It is close to major highways,
including I-95 and I-76. For directions, call 215-349-8387.

Accommodations
The Rittenhouse has a limited number of hotel rooms available for attendees
of this conference ($175 plus tax for single occupancy). For reservations,
please call the Rittenhouse at 215-546-9000, identifying this conference by
name.


Program  Schedule
Morning Session Presentations

8:00-8:30
Registration/Continental Breakfast

8:30-8:45
Welcome and Introduction
John H. Glick, MD
Barbara L. Weber, MD

8:45-9:15
New Perspectives on Cancer as a Hereditary Disease
Kenneth Offit, MD, MPH

9:15-9:30
Question/Answer Session

9:30-10:00
The Genetics of Breast Cancer
Barbara L. Weber, MD

10:00-10:15
Question/Answer Session

10:15-10:45
Genes and Susceptibility to Melanoma
DuPont Guerry, IV, MD

10:45-11:00
Question/Answer Session

11:00-11:15
Break

11:15-11:45
Genetic Factors that Produce Familial Colorectal Cancer
C. Richard Boland, MD

11:45-12:00
Question/Answer Session

12:00-12:30
Genetic Diagnosis of Medullary Thyroid Cancer in the Setting of MEN-2A,
MEN-2B and FMTC
Jeffrey A. Norton, MD

12:30-12:45
Question/Answer Session

12:45-1:45
Lunch


Afternoon Session Presentations
1:45-2:15
Counseling and Psychosocial
Issues in Genetic Testing for
Cancer Risk
Kathleen A. Calzone, RN, BSN

2:15-2:30
Video Presentation

2:30-3:00
Jill E. Stopfer, M.S., CGC

3:00-3:15
Question/Answer Session

3:15-3:45
Predictive Testing: The Insurer's Perspective
Gary M. Owens, MD

3:45-4:00
Question/Answer Session

4:00-4:30
Is Knowledge Always a Good Thing? Ethics and Genetics Testing for Cancer
Arthur L. Caplan, PhD

4:30-4:45
Question/Answer Session

Services for the Disabled
If special arrangements are required for an individual with a disability to
attend this meeting, please contact Julia Stein no later than December 8,
1995, at 215-349-8387.

Alec P. S. Schwartz (alecs@mail.med.upenn.edu)
University of Pennsylvania Cancer Center

Daytime:                         |Evening:
1223 Penn Tower (4283)           |1803 Pine Street
3400 Spruce Street               |Apartment 2-R
Philadelphia, PA  19104          |Philadelphia, PA  19103-6601
                                 |
(215) 349-8053                   |(215) 732-8705
(215) 349-8299 fax               |
____________________________________________________________________________
Subj:   Conference on DNA REPLICATION IN EUKARYOTES

This  message was  originally  submitted by  dellaire@ATLAS.ODYSSEE.NET to  the
HMG-MOLGEN list at  NIC.SURFNET.NL.

1st Announcement

The Fourth McGill University Conference on Regulation of Eukaryotic DNA Replication

St. Sauveur, Quebec, Canada
October 1996.

Organized by:

     Maria Zannis-Hadjopoulos and Gerald Price
     McGill Cancer Centre, Department of Oncology
     Faculty of Medicine and
     Faculty of Graduate Studies and Research
     McGill University

http://www.mcgill.ca/mcgill/servers/Admin/UBO/dna.html


The meeting will include plenary lecture
sessions and poster sessions.

TOPICS:

  * Eukaryotic Origins of DNA Replication
  * Nuclear and DNA Structure in DNA Replication
  * Modulation of Eukaryotic DNA Replication

Preliminary Program

The conference will be held at the Manoir Saint-Sauveur in the Laurentians. The first session will
begin in the evening of October 17 and the final session will end in the early afternoon of October
20. Poster and oral presentations will take place on October 18 and 19. All participants are
encouraged to present a poster on any of the topics that will be covered in the conference.


Conference Location:

The meeting will be held at the Laurentians' newest four-season conference resort hotel - a major
luxury complex just about 45 minutes from Montreal, amid the dynamic beauty of the Laurentians.
Saint-Sauveur-des-Monts, the Laurentians' most picturesque village, is the gateway village to the
Laurentians. Transportation will be available from the airport to the conference site, and return.

Registration materials and information regarding abstract submission will be sent in early 1996.


*********Abstract deadline date: June 27, 1996.************

For More Information

Please visit our Web Site

http://www.mcgill.ca/mcgill/servers/Admin/UBO/dna.html

>From this site you can obtain:

* A Preliminary Program
* Further Information on Conference Location
* A Reply Card to Obtain Registration Package

***************************************************************************
New Positions (many)


        The Department of Biology, San Francisco State University, is
searching for a Developmental Biologist with research interests in gene
expression associated with cell differentiation, pattern formation, or
signal transduction, using an animal or plant system.  The candidate is
expected to establish an active research program, direct masters-level
research students, seek extramural funding, and participate in the
undergraduate and graduate curriculum.  Teaching responsibilities will
primarily include upper division and graduate courses in developmental
biology.  San Francisco State University is a comprehensive university
whose faculty maintain strong commitment to teaching as well as to
conducting and directing research.

        The position is for an Assistant or Associate Professor.  A Ph.D.
is required and postdoctoral experience is desirable.

        The Department consists of 35 faculty with diverse research
programs in Cell and Molecular Biology and Microbiology, and Organismal and
Population Biology.  The successful applicant will have access to
departmental core facilities that support research and teaching functions
that house state-of-the art equipment including an automated sequencer and
robotics.

        Questions regarding the position may be addressed to Michael A.
Goldman, Chair, Developmental Biologist Search Committee, telephone
number, 415-338-7671; e-mail, goldman@sfsu.edu, or at the address below.

        Applicants should forward a curriculum vitae, statements of
teaching interests and research interests, and three letters of reference
by 15 December, 1995, to Chair, Hiring Committee, Department of Biology,
San Francisco State University, San Francisco, CA 94132.  Women, ethnic
minorities, and persons with disabilities are urged to apply.  SFSU is an
Equal Opportunity/Affirmative Action Employer.

------------------------------------------------------------
Michael A. Goldman, PhD.
Professor
Department of Biology
San Francisco State University
San Francisco, CA  94132-1722

Internet: goldman@sfsu.edu
     Tel: (415) 338-7671
     Fax: (415) 338-2295

"Scientists have already cast much darkness upon the subject,
 and if they continue their investigations we shall soon know
 nothing at all about it."  -- Mark Twain

"An expert is someone who learns more and more about less and
less until finally he knows everything about nothing."
-------------------------------------------------------------
From:   IN%"ED-MOLGEN@nic.SURFnet.nl"  "Human Molecular Genetics Editors" 13-NOV-1995 18:31:03.84
To:     IN%"ED-MOLGEN@nic.SURFnet.nl"  "Multiple recipients of list ED-MOLGEN"
CC:
Subj:   anno: open postdoc position in Biochemistry/Immunology

This message was  originally submitted by Goetz.Baumann@PKFMRG.PHARMA.SANDOZ.CH
to the HUM-MOLGEN list at NIC.SURFNET.NL.

We invite applications for a 'Postdoctoral Fellow' position in
our 'Inflammation' department of 'Preclinical Research', Sandoz
Pharma Ltd., Basel, Switzerland to work in a team on:

'Gene identification by oligonucleotide fingerprinting and
profiling of gene expression in Rheumatoid Arthritis'

Please send your detailed application as soon as possible to:
Dr. Gotz Baumann
Preclinical Research
c/o Sandoz Pharma Ltd.
CH-4002 Basel, Switzerland

For questions and further information please contact by:
E-mail:            GOETZ.BAUMANN@SANDOZ.CH
Tel.               +41 61 324 5913
Fax.               +41 61 324 2990

________________________________________________________________________

Subj:   ANNO: positions at Boehringer Mannheim GmbH


This message was originally submitted by JOSEF_STURM_at_DEPZ-PERSONAL@BMG.CORAN
GE.COM to the HUM-MOLGEN list at  NIC.SURFNET.NL.

     R & D Scientist - Boehringer Mannheim GmbH Germany
     This is a permanent position located in Penzberg (Upper-Bavaria / near
     Munich).
     Your task would be to contribute to R&D -projects in the area of bone
     metabolism. You will be supported by your own little staff of
     technicians.
     You should be experienced in molecular developmental genetics and
     molecular cell biology. Ph.D. is necessary. Post Doctoral experience
     and / or first experience in leadership would be of advantage. Your
     German and English should be almost fluent.
     If you are interested in the position please send your complete
     application in paper form to:
     Boehringer Mannheim GmbH, Werk Penzberg, Personalreferat Penzberg 3,
     Nonnenwald 2, D-82377 Penzberg
     P.S.:      Please use the code: ,hum-molgen position 01 BM" in your
     application form.


     R & D Neurobiologist - Boehringer Mannheim GmbH Germany
     Permanent position available at BM in Penzberg (Upper-Bavaria / near
     Munich).
     The cell biology department invites now applications for the position
     of a young highly
     motivated neurobiologist.
     Your task would be to establish  primary cell-culture models for
     neurodegenerative diseases, to implement neuronal screening-assays and
     to develop viral expression-systems for neuronal cells. Furthermore
     you would have to produce and characterise monoclonal antibodies for
     different project groups. You will be supported by your own little
     staff of technicians.
     Ph.D. is necessary. Post Doctoral experience and / or first experience
     in leadership would be of advantage. Your German and English should be
     almost fluent.
     If you are interested in the position please send your complete
     application in paper form to:
     Boehringer Mannheim GmbH, Werk Penzberg, Personalreferat Penzberg 3,
     Nonnenwald 2, D-82377 Penzberg
     P.S.:      Please use the code: ,hum-molgen position 02 BM" in your
     application form.
___________________________________________________________________________

Subj:   Competitive Sabbatical Positions

The Visiting Investigator Program
National Center for Human Genome Research
National Insitutes of Health (NIH)

The Visiting Investigator Program  is a competitive program that provides
tenured or tenure-tract faculty level scientists from outside the NIH with
the opportunity to spend a 3 - 12 month period  at the National Center for
Human Genome Research (NCHGR) laboratories and clinics at the NIH.  Basic
and clinical genetic researchers and social scientists can use their stay
at the NCHGR to learn new technologies, develop research collaborations, or
pursue sabbatical research projects.

For application materials and information, contact:
http://www.nchgr.nih.gov/dir/vip/

Betty Wolf-Ledbetter
Director, Visiting Investigator Program

National Center for Human Genome Research
NIH, Building 9/1E106
9 Center Drive  MSC 0950
Bethesda, MD    20892-0950
Tel:   (301) 402-2012
Fax:  (301) 402-2440
E-Mail:  vip@nchgr.nih.gov
__________________________________________________________________________
Subj:   postdoc position

This message was originally  submitted by nerk057@RZBOX.UNI-WUERZBURG.DE to the
HUM-MOLGEN list at  NIC.SURFNET.NL.

Department of Psychiatry

Post-doctoral Position
(Molecular Biologist/Geneticist)

is available immediately to identify and study genes involved in psychiatric
disorders. Our group presently focusing on gene expression is expanding its
scope on novel gene mapping techniques. Applicants must have completed a Ph.D
and should have at least two years of postdoctoral experience with
several of
the following experimental approaches presently used in the lab: advanced
molecular biology and biochemistry techniques relevant to positional cloning,
mammalian cell culture, mouse genetics (gene targeting & transgenics). The
successful candidate will join a multidisciplinary environment with rich
collaborative opportunities in basic and clinical research. Salary
approx. DM
99.300 p.a. (BAT IIa). Please send cv, a description of research
experience and
the names and phone numbers of three references to:
K.P. Lesch, M.D., Department of Psychiatry, University of Wuerzburg,
Fchsleinstr. 15, D-97080 Wuerzburg, Germany
_______________________________________________________________________
Subj:   ANNO: Postdoc position - cytokine receptor activation

This message  was originally  submitted by TGONDA@IMMUNO.IMVS.SA.GOV.AU  to the
HUM-MOLGEN list at  NIC.SURFNET.NL.

POST-DOCTORAL POSITION - CYTOKINE RECEPTOR ACTIVATION

Hanson Centre for Cancer Research
Institue of Medical and Veterinary Science
Adelaide, South Australia

PROJECT: Analysis of activating mutations in the beta
subunit of the granulocyte-macrophage colony stimulating
(GM-CSF) factor receptor.

BACKGROUND: The GM-CSF receptor comprises two subunits,
(alpha and beta) which are both members of the cytokine
receptor superfamily.  We have recently identified a
number of mutations in the beta subunit (ref. EMBO J
14:4276-4287 (1995)) which result in its constitutive
activity.  These mutations and allow proliferation of
normally factor-dependent cells in the absence of exogenous
GM-CSF and are oncogenic in such cell lines. Current
studies in the laboratory aim to:
 - elucidate how these mutations activate the beta subunit;
 - examine the intracellular signalling pathways triggered by the
activated receptor in different cell types;
 - identify other components of the receptor complex that are
 required for receptor signalling.

The findings from these studies will be relevant to
understanding normal GM-CSF receptor function - and by
analogy, that of other cytokine receptors - and will allow
investigation of the potential role of the beta subunit in
leukaemia.

FURTHER INFORMATION:
Contact Dr Tom Gonda on phone: +61-8-222-3305; FAX +61-8-232-4092;
E-mail: tgonda@immuno.imvs.sa.gov.au
____________________________________________
____________________________________________
Tom Gonda
Hanson Centre for Cancer Research
Institute of Medical and Veterinary Science
Frome Road, Adelaide, SA 5000
Australia

Ph. +61-8-222-3305
FAX +61-8-232-4092


   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Mail converted by MHonArc 2.4.4
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 1995-2001 HUM-MOLGEN. All rights reserved. Liability and Copyright.